CEVA, Inc.

Executive Summary

SELL, Medium conviction. Rated SELL, Medium conviction. CEVA has real licensing momentum and raised its FY26 outlook, yet the shares trade at 6.96x TTM sales, above the 6.1x peer average, despite negative LTM operating and free-cash-flow generation. The stock is already 44.0% below its 52-week high, but that drawdown reflects a warranted reset in a business whose non-GAAP recovery has not yet become GAAP profit.

Investment Thesis

CEVA should be avoided at $28.88 because the market is paying a premium sales multiple before the company has established repeatable GAAP earnings or free-cash-flow generation. The operating model can become highly profitable once royalties scale, but that operating leverage cuts both ways. LTM revenue is only about $0.1B, and a relatively small change in handset, IoT, or licensing timing can materially alter the earnings outcome. The current price leaves little room for that volatility.

The favorable part of the case is real. Licensing and related revenue grew 21% in Q2, the company won a strategic NeuPro-M license, and platform-level contracts can increase both initial license value and the chance of later royalties. Management's full-year outlook also calls for expenses to grow only about 8%, below revenue growth. If those contracts progress from development to high-volume silicon, CEVA's asset-light model could support a much better profit profile than its recent reported results.

The issue is the gap between that possibility and what investors own today. Q2's non-GAAP operating gain does not erase the GAAP loss, and FY25's negative EPS shows that a modest revenue improvement has not yet produced durable reported earnings. The company also has exposure to mobile demand and industrial IoT, where shipment data weakened. Unlike a broad semiconductor supplier, CEVA is reliant on customers choosing its architecture early in chip design cycles, then successfully shipping the finished devices years later.

AI is the pivotal variable. Edge inference favors low-power NPUs and can expand CEVA's addressable market in automotive, consumer devices, and connectivity. It also intensifies competition from internally designed accelerators, Arm-adjacent ecosystems, and larger semiconductor vendors that can bundle hardware, software, and IP. The medium conviction reflects this asymmetry: the technology may merit a future premium, but the current valuation assumes too much of that future before royalty conversion and GAAP profitability are visible.

Key Metrics

Financial Strength

CEVA has substantial liquidity protection through a 10.12 current ratio as of 2026-06-30 and minimal leverage, so financial distress is not the issue. The weakness is earnings quality and cash conversion: LTM net margin was negative and free cash flow was slightly negative on a rounded basis. Gross margins can remain exceptional in an IP model, but the fixed operating-cost base requires licensing and royalties to scale consistently before the balance-sheet strength becomes a shareholder-return engine.

Competitive Position

CEVA sells embedded IP that customers integrate into wireless, sensing, and edge-AI chips, creating switching friction once a design is qualified and reaches production. Its 88% non-GAAP Q2 gross margin indicates the economic advantage of the IP model, while the NeuPro-M license and broader platform deals suggest CEVA can sell more complete solutions rather than isolated cores. The moat is only moderately durable: large semiconductor customers can develop internally, and AI silicon architectures are moving quickly enough that present design wins do not guarantee relevance in three to five years.

Management & Guidance

Management now expects FY26 revenue growth of 13%-15%, with approximately 8% growth in non-GAAP cost of revenue plus OpEx, roughly 70% growth in non-GAAP operating income, and roughly 50% growth in non-GAAP net income. The near-term test is Q3 revenue guidance of $30.5M-$34.5M and approximately 88% non-GAAP gross margin. The guidance is more credible after Q2 revenue and expense control, but the wide $4M Q3 revenue range and the continuing GAAP loss justify treating it as an operating target rather than proof of a completed turnaround.

Segment Analysis

• Licensing and related revenue (Share not disclosed): Q2 revenue grew 21% YoY to its highest level in three years, driven by broader platform agreements and 10 signed deals.
• Royalty revenue (Share not disclosed): Revenue rose 17% QoQ in Q2, supported by connectivity, automotive AI, and smartphone share gains.
• Industrial IoT end market (Share not disclosed): Shipment volume fell 21% YoY to 19M units in Q2, making it the clearest disclosed weak end market.
• Geographic revenue (Not disclosed): The supplied disclosures do not provide country or regional revenue, preventing a quantified geographic concentration assessment.

Capital Allocation

The balance sheet is conservatively financed, with 0.05 debt/equity as of 2026-06-30 and total debt rounded to $0.0B, but LTM free cash flow was also rounded to -$0.0B, leaving no demonstrated surplus for shareholder returns. LTM capex, buybacks, and dividends were each $0.0B, so capital deployment has been inactive rather than a source of upside. The board had more than 1M shares available under authorization in the 2024 Q3 call, but no current-period repurchase execution is disclosed.

Management Execution & Track Record

Management entered the 2024 Q3 call guiding FY24 revenue growth of 7%-9%, Q4 revenue of $26.5M-$28.5M, and roughly doubled non-GAAP EPS versus FY23. The supplied dataset does not provide FY24 full-year actual revenue, margins, or EPS, so that precise annual promise cannot be scored as hit or miss. What can be measured since then is stronger operating momentum: Q2 2026 revenue was $29M, versus $27.2M in the historical Q3, and current FY26 growth guidance is 13%-15%, above the prior 12% outlook. Management also delivered on cost control in Q2, with $22.3M non-GAAP OpEx at the low end of guidance, and has beaten or met EPS estimates in 7 of 8 recent quarters. Credibility is therefore improving on quarterly delivery, but the persistence of a $2.9M GAAP Q2 loss means the promised earnings-power transition remains incomplete.

Positioning & Flows

Institutional ownership is concentrated, with the top three institutions holding 73.7%, while insider ownership is only 3.7%. Short interest of 12.16% is material but slipped 1.4%, so it is not evidence of an escalating short campaign. Options gamma is negative and the zero-gamma level is $33.57, above spot, which can amplify downside below that threshold rather than create a reliable squeeze setup.

Bull Case

• Q2 revenue reached $29M, up 13% YoY and 7% QoQ, with royalty revenue up 17% QoQ from connectivity, automotive AI, and smartphone share gains.
• Non-GAAP operating margin reached 11% in Q2, up from 3% a year earlier, while non-GAAP OpEx of $22.3M landed at the low end of guidance.
• The Q2 sales cycle produced two first-time customers and two OEMs among 10 agreements, expanding the potential royalty base beyond existing accounts.
• CEVA beat or met EPS estimates in 7 of the last 8 reported quarters, including a 9.2% beat in August 2026.

Bear Case

• GAAP Q2 net loss was $2.9M, and LTM operating margin was -8.3%, so the reported business remains loss-making despite the non-GAAP recovery.
• FY25 EPS was -$0.44, down 55.2% YoY, making the current valuation dependent on a profit inflection that has not appeared in audited annual earnings.
• Industrial IoT shipments fell 21% YoY to 19M units in Q2, and management flagged memory supply and pricing as a second-half handset demand variable.
• Short interest is 12.16% of float, or 3.11M shares and 4.2 days to cover, reflecting a meaningful bearish ownership cohort rather than a clean technical base.

Valuation & Price Target

Engine price target $23.62 (-18.2% vs current), Medium confidence.

• P/S Multiple: $20.97 (45% weight)
• Quality-adjusted: $29.57 (20% weight)

The SELL rating agrees with the quantitative baseline and its $23.62 target, which implies -18.2% downside. The blend is internally sensible: the sales-based value is $20.97, while a quality-adjusted value of $29.57 gives credit for high gross margin, net cash-like balance-sheet characteristics, and the AI-IP pipeline. This note gives more weight to the lower leg because CEVA's 53/100 quality score includes weak growth potential and shareholder returns, while the 56/100 moderate risk score is dominated by 19.8/25 execution risk. Sell-side consensus is Strong Buy from six firms, but that low-signal view does not resolve the gap between non-GAAP guidance and negative LTM GAAP profitability.

Risk Assessment

Risk score 56/100 (Moderate). The central downside risk is that licensing momentum does not translate into royalty and GAAP-profit conversion, leaving CEVA valued at 6.96x TTM sales with a -8.3% LTM operating margin.

The Bottom Line

CEVA rates a SELL at Medium conviction for the next 6-12 months. The company has meaningful AI-IP optionality and a clean balance sheet, but the shares still value that optionality above peer sales levels while reported profitability is negative. A sustained conversion of new licenses into royalties, GAAP operating profit, and positive free cash flow would change the view. Until then, the more probable path is convergence toward the $23.62 base value rather than a return toward the prior high.